Search Results 1651-1660 of 27372 for female
Female participants or female partners of male participants must not be pregnant or plan to become pregnant for the duration of the trial and for up to 90 ...
- Female patient is either not of childbearing potential, defined as postmenopausal for at least 1 year or surgically sterile, or is of childbearing ...
Participation eligibility · Pregnancy. · Females who are pregnant or breast-feeding during the study period will be excluded. · Distant metastatic disease not ...
... female or a female of childbearing potential while participating in the study, during dose interruptions and for at least 90 days after the last dose of CC ...
Reproductive development & function of the female reproductive system. In: Ganong's Review of Medical Physiology. 26th ed. McGraw Hill; 2019. https ...
Caregiver access for adults is not available in Primary Care On Demand. Adult patients will need to download and log in to the app with their patient portal ...
Male or female aged 18 years and older. Females of childbearing potential must have a negative pregnancy test prior to receiving the study drug and will ...
Learn about this genetic disorder that causes developmental delays, problems with speech and other symptoms.
Females of childbearing potential (FCBP) must: ... Practice complete abstinence1 or agree to use a condom during sexual contact with a pregnant female or a female ...
Documented diagnosis of multiple myeloma: · Subjects must have measurable disease, including at least one of the criteria below: · Females of childbearing ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!